Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase

被引:345
作者
Franklin, Christopher C. [1 ]
Backos, Donald S. [1 ]
Mohar, Isaac [2 ]
White, Collin C. [2 ]
Forman, Henry J. [3 ]
Kavanagh, Terrance J. [2 ]
机构
[1] Univ Colorado, Dept Pharmaceut Sci, Denver, CO 80262 USA
[2] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA
[3] Univ Calif, Sch Nat Sci, Merced, CA USA
关键词
Glutamate cysteine ligase; GCL; GCLC; GCLM; Glutathione; GSH; Post-translational; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; ACETAMINOPHEN-INDUCED HEPATOTOXICITY; GLUTATHIONE-RELATED GENES; HEPATIC STELLATE CELLS; HAMSTER V79 CELLS; OXIDATIVE STRESS; HEAVY SUBUNIT; DRUG-RESISTANCE; ACTIVE-SITE; STREPTOCOCCUS-AGALACTIAE;
D O I
10.1016/j.mam.2008.08.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glutathione (GSH) is a tripeptide composed of glutamate, cysteine, and glycine. The first and rate-limiting step in GSH synthesis is catalyzed by glutamate cysteine ligase (GCL, previously known as gamma-glutamylcysteine synthetase). GCL is a heterodimeric protein composed of catalytic (GCLC) and modifier (GCLM) subunits that are expressed from different genes. GCLC catalyzes a unique gamma-carboxyl linkage from glutamate to cysteine and requires ATP and Mg++ as cofactors in this reaction. GCLM increases the V-max and K-cat of GCLC. decreases the K-m for glutamate and ATP, and increases the K-i for GSH-mediated feedback inhibition of GCL While post-translational modifications of GCLC (e.g. phosphorylation, myristoylation, caspase-mediated cleavage) have modest effects on GCL activity, oxidative stress dramatically affects GCL holoenzyme formation and activity. Pyridine nucleotides can also modulate GCL activity in some species. Variability in GCL expression is associated with several disease phenotypes and transgenic mouse and rat models promise to be highly useful for investigating the relationships between GCL activity, GSH synthesis, and disease in humans. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:86 / 98
页数:13
相关论文
共 130 条
[1]   Structure prediction and active site analysis of the metal binding determinants γ-glutamyleysteine synthetase [J].
Abbott, JJ ;
Pei, JM ;
Ford, JL ;
Qi, Y ;
Grishin, VN ;
Phillips, MA ;
Grishin, NV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :42099-42107
[2]   Knock down of γ-glutamylcysteine synthetase in rat causes acetaminophen-induced hepatotoxicity [J].
Akai, Sho ;
Hosomi, Hiroko ;
Minami, Keiichi ;
Tsuneyama, Koichi ;
Katoh, Miki ;
Nakajima, Miki ;
Yokoi, Tsuyoshi .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (33) :23996-24003
[3]  
[Anonymous], 2000, SCI STKE, DOI DOI 10.1126/STKE.2000.48.PE1
[4]   Transforming growth factor-beta(1) is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: Transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase [J].
Arsalane, K ;
Dubois, CM ;
Muanza, T ;
Begin, R ;
Boudreau, F ;
Asselin, C ;
Cantin, AM .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (05) :599-607
[5]   Smad3-ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying proteins [J].
Bakin, AV ;
Stourman, NV ;
Sekhar, KR ;
Rinehart, C ;
Yan, XX ;
Meredith, MJ ;
Arteaga, CL ;
Freeman, ML .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 38 (03) :375-387
[6]   Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins [J].
Ballatori, N ;
Hammond, CL ;
Cunningham, JB ;
Krance, SM ;
Marchan, R .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 204 (03) :238-255
[7]   Polymorphisms and vascular cognitive impairment after ischemic stroke [J].
Baum, Larry ;
Chen, Xiangyan ;
Cheung, Wing Sze ;
Cheung, Chi Kin Arthur ;
Cheung, Lap Woon ;
Chiu, Ka Fung Peter ;
Wen, Hong Mei ;
Poon, Peter ;
Woo, Kam Sang ;
Ng, Ho Keung ;
Wong, Ka Sing .
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2007, 20 (02) :93-99
[8]   Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels [J].
Bekris, L. M. ;
Shephard, C. ;
Janer, M. ;
Graham, J. ;
McNeney, B. ;
Shin, J. ;
Zarghami, M. ;
Griffith, W. ;
Farin, F. ;
Kavanagh, T. J. ;
Lernmark, A. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (04) :221-228
[9]   Chronic beryllium disease and glutathione biosynthesis genes [J].
Bekris, Lynn M. ;
Viernes, Hannah-Malia A. ;
Farin, Federico M. ;
Maier, Lisa A. ;
Kavanagh, Terrance J. ;
Takaro, Tim K. .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2006, 48 (06) :599-606
[10]  
BEUTLER E, 1990, BLOOD, V75, P271